DUBLIN, IRELAND--(Marketwire - February 12, 2008) - Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that Brendan Farrell, Chief Executive Officer will be speaking at the Roth Capital Partners 20th Annual OC Growth Stock Conference at 08:00 a.m. Pacific Time, on Tuesday the 19th of February. The event will be webcast and can be accessed on http://wsw.com/webcast/roth16/trib/
